Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1993; 22:2001-2006
© 1993 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Battler, A
Right arrow Articles by Eldar, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Battler, A
Right arrow Articles by Eldar, M

Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium

A Battler, M Scheinowitz, A Bor, D Hasdai, Z Vered, E Di Segni, N Varda-Bloom, D Nass, S Engelberg, M Eldar, et al.

Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Aviv, Israel.

OBJECTIVES. This study was performed to examine the effect of intracoronary exogenous basic fibroblast growth factor (bFGF) on angiogenesis in infarcted myocardial regions. BACKGROUND. Exogenous bFGF is a potent promoter of angiogenesis. Little information is available on its effect on myocardial angiogenesis. METHODS. Myocardial infarction was induced in 10 pigs by intracoronary injection of microscopic beads. Four pigs served as a control group; in six pigs slow-release bFGF was delivered by the beads. Cardiac performance was evaluated by repeated echocardiographic measurement and angiogenesis was evaluated by immunohistochemical studies 14 days later. RESULTS. As compared with control pigs, pigs treated with bFGF had higher microvessel counts (mean +/- SEM) in both viable tissue (141 +/- 27 per field vs. 39 +/- 4, p = 0.01) and nonviable tissue (329 +/- 26 per field vs. 95 +/- 7, p < 0.001) within the infarct area. No significant differences in total regional left ventricular wall motion were noted between the two groups throughout the 14-day study period. CONCLUSIONS. In the swine, direct intracoronary application of bFGF to infarcted myocardium enhances myocardial neovascularization within 2 weeks.


This article has been cited by other articles:


Home page
Toxicol PatholHome page
S. U. Lee, J. J. Wykrzykowska, and R. J. Laham
Angiogenesis: Bench to Bedside, Have We Learned Anything?
Toxicol Pathol, January 1, 2006; 34(1): 3 - 10.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Hosaka, H. Koyama, T. Kushibiki, Y. Tabata, N. Nishiyama, T. Miyata, H. Shigematsu, T. Takato, and H. Nagawa
Gelatin Hydrogel Microspheres Enable Pinpoint Delivery of Basic Fibroblast Growth Factor for the Development of Functional Collateral Vessels
Circulation, November 23, 2004; 110(21): 3322 - 3328.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
K. Nakamura, S. Hirohata, T. Murakami, T. Miyoshi, K. Demircan, T. Oohashi, H. Ogawa, K. Koten, K. Toeda, S. Kusachi, et al.
Dynamic Induction of ADAMTS1 Gene in the Early Phase of Acute Myocardial Infarction
J. Biochem., October 1, 2004; 136(4): 439 - 446.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. C Hershey, H. A Corcoran, E. P Baskin, D. B Gilberto, X. Mao, K. A Thomas, and J. J Cook
Enhanced hindlimb collateralization induced by acidic fibroblast growth factor is dependent upon femoral artery extraction
Cardiovasc Res, October 1, 2003; 59(4): 997 - 1005.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. von Degenfeld, P. Raake, C. Kupatt, C. Lebherz, R. Hinkel, F. J. Gildehaus, W. Munzing, A. Kranz, J. Waltenberger, M. Simoes, et al.
Selective Pressure-Regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1120 - 1128.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A-A Kotlyar, Z Vered, I Goldberg, P Chouraqui, D Nas, E Fridman, Z Chen-Levy, S Fytlovich, G Sangiorgi, L G Spagnoli, et al.
Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine
Heart, December 1, 2001; 86(6): 693 - 700.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R Tabibiazar and S.G Rockson
Angiogenesis and the ischaemic heart
Eur. Heart J., June 1, 2001; 22(11): 903 - 918.
[PDF]


Home page
Cardiovasc ResHome page
E. F Unger
Experimental evaluation of coronary collateral development
Cardiovasc Res, February 16, 2001; 49(3): 497 - 506.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Post, R. Laham, F. W. Sellke, and M. Simons
Therapeutic angiogenesis in cardiology using protein formulations
Cardiovasc Res, February 16, 2001; 49(3): 522 - 531.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Laham, N. A. Chronos, M. Pike, M. E. Leimbach, J. E. Udelson, J. D. Pearlman, R. I. Pettigrew, M. J. Whitehouse, C. Yoshizawa, and M. Simons
Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a Phase I open-label dose escalation study
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2132 - 2139.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. E. Udelson, V. Dilsizian, R. J. Laham, N. Chronos, J. Vansant, M. Blais, J. R. Galt, M. Pike, C. Yoshizawa, and M. Simons
Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 Improves Stress and Rest Myocardial Perfusion Abnormalities in Patients With Severe Symptomatic Chronic Coronary Artery Disease
Circulation, October 3, 2000; 102(14): 1605 - 1610.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Kawasuji, H. Nagamine, M. Ikeda, N. Sakakibara, H. Takemura, S. Fujii, and Y. Watanabe
Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor
Ann. Thorac. Surg., April 1, 2000; 69(4): 1155 - 1161.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. J. Laham, M. Rezaee, M. Post, D. Novicki, F. W. Sellke, J. D. Pearlman, M. Simons, and D. Hung
Intrapericardial Delivery of Fibroblast Growth Factor-2 Induces Neovascularization in a Porcine Model of Chronic Myocardial Ischemia
J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 795 - 802.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
L. M Goncalves
Angiogenic growth factors: potential new treatment for acute myocardial infarction?
Cardiovasc Res, January 14, 2000; 45(2): 294 - 302.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. T. Yang and Y. Feng
bFGF increases collateral blood flow in aged rats with femoral artery ligation
Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H85 - H93.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. J. Laham, M. Rezaee, M. Post, F. W. Sellke, R. A. Braeckman, D. Hung, and M. Simons
Intracoronary and Intravenous Administration of Basic Fibroblast Growth Factor: Myocardial and Tissue Distribution
Drug Metab. Dispos., July 1, 1999; 27(7): 821 - 826.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
J. R Kersten, P. S Pagel, W. M Chilian, and D. C Warltier
Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia
Cardiovasc Res, July 1, 1999; 43(1): 44 - 57.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
T. Hasegawa, A. Kimura, M. Miyataka, M. Inagaki, and K. Ishikawa
Basic Fibroblast Growth Factor Increases Regional Myocardial Blood Flow and Salvages Myocardium in the Infarct Border Zone in a Rabbit Model of Acute Myocardial Infarction
Angiology, June 1, 1999; 50(6): 487 - 495.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. J. Laham, M. Simons, M. Tofukuji, D. Hung, and F. W. Sellke
MODULATION OF MYOCARDIAL PERFUSION AND VASCULAR REACTIVITY BY PERICARDIAL BASIC FIBROBLAST GROWTH FACTOR: INSIGHT INTO ISCHEMIA-INDUCED REDUCTION IN ENDOTHELIUM-DEPENDENT VASODILATATION
J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 1022 - 1028.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. W. Sellke, R. J. Laham, E. R. Edelman, J. D. Pearlman, and M. Simons
Therapeutic Angiogenesis With Basic Fibroblast Growth Factor: Technique and Early Results
Ann. Thorac. Surg., June 1, 1998; 65(6): 1540 - 1544.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
M. Miyataka, K. Ishikawa, and R. Katori
Basic Fibroblast Growth Factor Increased Regional Myocardial Blood Flow and Limited Infarct Size of Acutely Infarcted Myocardium in Dogs
Angiology, May 1, 1998; 49(5): 381 - 390.
[Abstract] [PDF]


Home page
ScienceHome page
Beauty in simplicity.
Science, April 17, 1998; 280(5362): 456 - 457.
[Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. J. Lopez, E. R. Edelman, A. Stamler, M. G. Hibberd, P. Prasad, K. A. Thomas, J. Disalvo, R. P. Caputo, J. P. Carrozza, P. S. Douglas, et al.
Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia
Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H930 - H936.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Waltenberger
Modulation of Growth Factor Action : Implications for the Treatment of Cardiovascular Diseases
Circulation, December 2, 1997; 96(11): 4083 - 4094.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
M. E. Staab, R. D. Simari, S. S. Srivatsa, D. Hasdai, V. J. Pompili, D. R. Holmes, R. S. Schwartz, and R. S. Schwartz
Enhanced Angiogenesis and Unfavorable Remodeling in Injured Porcine Coronary Artery Lesions: Effects of Local Basic Fibroblast Growth Factor Delivery
Angiology, September 1, 1997; 48(9): 753 - 760.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. J. Lopez, E. R. Edelman, A. Stamler, M. G. Hibberd, P. Prasad, R. P. Caputo, J. P. Carrozza, P. S. Douglas, F. W. Sellke, and M. Simons
Basic Fibroblast Growth Factor in a Porcine Model of Chronic Myocardial Ischemia: A Comparison of Angiographic, Echocardiographic and Coronary Flow Parameters
J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 385 - 390.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. S. Pepper
Manipulating Angiogenesis: From Basic Science to the Bedside
Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 605 - 619.
[Abstract] [Full Text]


Home page
CirculationHome page
J.-W. Gu, D. Santiago, Y. Olowe, and J. Weinberger
Basic Fibroblast Growth Factor as a Biochemical Marker of Exercise-Induced Ischemia
Circulation, March 4, 1997; 95(5): 1165 - 1168.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. D. Mannion, V. Blood, W. Bailey, T. L. Bauer, M. G. Magno, F. DiMeo, A. Epple, and F. G. Spinale
THE EFFECT OF BASIC FIBROBLAST GROWTH FACTOR ON THE BLOOD FLOW AND MORPHOLOGIC FEATURES OF A LATISSIMUS DORSI CARDIOMYOPLASTY
J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 19 - 28.
[Abstract] [Full Text]


Home page
CirculationHome page
V. J. Dzau, G. H. Gibbons, B. K. Kobilka, R. M. Lawn, and R. E. Pratt
Genetic Models of Human Vascular Disease
Circulation, January 15, 1995; 91(2): 521 - 531.
[Abstract] [Full Text]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement